polymyxin b nonapeptide has been researched along with clarithromycin in 2 studies
Studies (polymyxin b nonapeptide) | Trials (polymyxin b nonapeptide) | Recent Studies (post-2010) (polymyxin b nonapeptide) | Studies (clarithromycin) | Trials (clarithromycin) | Recent Studies (post-2010) (clarithromycin) |
---|---|---|---|---|---|
11 | 0 | 5 | 7,149 | 1,606 | 2,504 |
Protein | Taxonomy | polymyxin b nonapeptide (IC50) | clarithromycin (IC50) |
---|---|---|---|
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 5.5 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 3.3113 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.0903 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
Apajalahti, J; Fox, J; Frimodt-Møller, N; He, H; Li, J; Nation, RL; Poudyal, A; Siikanen, O; Vaara, M; Vaara, T | 1 |
2 other study(ies) available for polymyxin b nonapeptide and clarithromycin
Article | Year |
---|---|
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Cricetinae; Cricetulus; Drug Synergism; Fibroblasts; Gram-Negative Bacteria; Guinea Pigs; Lung; Male; Microbial Sensitivity Tests; Polymyxin B; Rats; Structure-Activity Relationship | 2010 |